Navigation Links
Unigene Provides 2012 Business Outlook
Date:1/9/2012

program
  • Continue to build a robust portfolio of feasibility programs with various pharmaceutical companies evaluating Unigene's industry-leading Peptelligence™ platform for oral delivery of proprietary peptides across a broad spectrum of therapeutic areas
  • Convert at least one Peptelligence™ feasibility study into a definitive license agreement associated with significant milestones and royalties
  • File an IND and begin Phase 1 clinical testing of Unigene's lead metabolic peptide, UGP281, targeting patients with morbid obesity
  • Select lead molecule for Type 2 diabetes indication under joint development vehicle (JDV) with Nordic Bioscience
  • Announce preclinical results for Type 2 diabetes indication under JDV with Nordic Bioscience
  • Palmer continued, "We have established Unigene as the oral peptide delivery innovator and partner-of-choice, and we are now ideally positioned to capitalize on the numerous opportunities our industry leading oral peptide delivery platform can realize in 2012.  In addition, we intend to secure a superb development and commercialization partner for our oral PTH program, a high-value asset with the potential to provide a more compliant and patient friendly therapy for the estimated 75 million osteoporosis sufferers worldwide."

    Palmer concluded, "Prospects for the successful turnaround and long-term future of Unigene have never been brighter or more realizable.  Given this cautious optimism and confidence, all members of Unigene's senior management team and I, along with our Board of Directors, have chosen to increase our personal investments in Unigene, to demonstrate our strong commitment to the Company and our belief in our ability to execute our targeted growth strategy in 2012."

    Unigene Therapeutics Outlook

    Unigene is focused on advancing its own pipeline of novel, proprietary peptide product candidates focused on metabolic disease
    '/>"/>

    SOURCE Unigene Laboratories, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
    2. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
    3. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
    4. Unigene Reports Third Quarter 2011 Financial Results
    5. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
    6. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
    7. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
    8. VIVUS Provides Qnexa Regulatory Update
    9. New Product Planning Excellence Services Program Provides Road Map for Clinical Development Success in the Pharmaceutical Industry
    10. ViroPharma Provides 2012 Outlook
    11. Cogmedix Provides High-Precision Subassembly for LensAR Revolutionary Refractive Laser
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the world,s ... dental, animal health and medical practitioners, announced today that the ... , September 4, 2014 – Baird 2014 Healthcare Conference ... ET , September 8, 2014 – Morgan ... , NY at 1:25 p.m. ET Henry Schein,s ...
    (Date:8/21/2014)... PARK, N.J. , Aug. 21, 2014 /PRNewswire/ ... pharmacy group purchasing organization (GPO), is pleased to ... to collaborate on a host of innovative specialty ... help Aurora deliver enhanced therapy management services to ... Management (OTM) system. Aurora will use ...
    (Date:8/21/2014)... WOONSOCKET, R.I. , Aug. 21, 2014 CVS ... early tender results, applicable Reference Yields and consideration payable in ... Offers") commenced on August 7, 2014 for (1) any and ... and All Notes") and (2) up to a maximum amount ... due 2041 and 5.750% Senior Notes due 2017 (collectively, the ...
    Breaking Medicine Technology:Henry Schein To Present At Two Investor Conferences In September 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
    ... Ill., Nov. 8, 2010 ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
    ... 8, 2010 Reportlinker.com announces that a ... its catalogue: The Future ... leading companies, and opportunities for target expansion ... G-Protein-coupled receptors (GPCRs) constitute the largest ...
    Cached Medicine Technology:Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 2Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 3Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 4Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 5Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 6Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 7Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 8The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 2The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 3The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 4The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 5
    (Date:8/21/2014)... (PRWEB) August 21, 2014 ... American Corporate Health, was recently recognized as ... professionals in the field of workers’ compensation. ... Workers’ Compensation and Occupational Medicine Conference was ... attorneys, physicians, nurses, case managers, disability specialists, ...
    (Date:8/21/2014)... As part of a continuing mission to ... joined with the Alliance for Safe Online Pharmacies (ASOP) ... sale of medicines. , “Helping to ensure the quality, ... a core mission for USP and an important tool ... T. Piervincenzi, chief executive officer of USP. “The illegal ...
    (Date:8/21/2014)... 21, 2014 According to a new ... Optics Market-Global Industry Analysis, Size, Share, Growth, Trends and ... market was valued at USD 863.1 million in 2013 ... 7.6% from 2013 to 2019, to reach an estimated ... medical fiber optics market is witnessing significant growth due ...
    (Date:8/21/2014)... According to a new market report ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... valued at USD 236.1 million in 2011 and is ... in 2018 at a CAGR of 6.3% from 2012 ... Report: http://www.transparencymarketresearch.com/fundus-cameras.html . , Fundus cameras market growth ...
    (Date:8/21/2014)... (PRWEB) August 21, 2014 The worlds ... offer customers an exciting chance to grab free products. ... all-natural deodorant from Tom's of Maine with all qualifying ... deodorant and our environmentally friendly yoga apparel is simply ... The joint promotion between the two brands is intended ...
    Breaking Medicine News(10 mins):Health News:Dr. Vasili Gatsinaris Named One of the Top 50 Most Influential in Workers’ Compensation 2Health News:USP Joins Efforts to Halt Illegal Online Drug Sales 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Fundus Cameras Market: Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices 2Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2
    ... and Company) (NYSE: BDX ), a global medical ... Bear Stearns 20th Annual,Healthcare Conference on Monday, September 10, ... of BD,s presentation can be accessed from the BD,corporate ... for replay,through Monday, September 17, 2007. BD, a ...
    ... Pa., Aug. 30 As part of his work,to ... health,insurance, Governor Edward G. Rendell today said 35,000 uninsured,individuals ... Insurance,Program will be given the opportunity to receive health ... insurance brings a sense of security and peace of ...
    ... pathway in the most common and aggressive type of ... to fuel tumor growth and help cancers evade drug ... In a series of laboratory and animal experiments, Johns ... with an experimental compound called cyclopamine to explore the ...
    ... reduce or prevent allergic reactions, group suggests , THURSDAY, ... people with seasonal allergies may suffer oral allergy syndrome ... pollen proteins from weeds, grass and trees and similar ... symptoms of OAS -- also known as pollen-food syndrome ...
    ... The sort of swelling that occurs when a joint ... the healing process, but when it comes to the knee, ... findings in experiments with pigs may lead to treatments for ... Medical Center orthopedic researchers. There are drugs that can block ...
    ... with the respiratory condition , , WEDNESDAY, Aug. 29 (HealthDay ... guidelines Wednesday that seek to make breathing easier and ... the lung disease. , "Asthma control is achievable for ... the National Heart, Lung, and Blood Institute, said during ...
    Cached Medicine News:Health News:Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians 2Health News:Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells 2Health News:Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells 3Health News:Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome 2Health News:New insights into common knee injuries 2Health News:New Asthma Guidelines Stress Disease Control 2Health News:New Asthma Guidelines Stress Disease Control 3
    Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
    ... Inductive demineralized bone matrix ... and cancellous chips will be ... bone matrix particle size is ... chip particle size is 1 ...
    Demineralized cortical fibers and cancellous chips....
    ... positioning flexibility while permitting the components to be ... transport. The system has a small footprint to ... the same time offers the surgeon total control ... and display of the Stealthstation Treon can be ...
    Medicine Products: